Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIZZICATO: Ritlecitinib and Brepocitinib in Crohn's Disease
NCT03395184Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2018
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 2 trial of ritlecitinib tosilate, brepocitinib in Crohn's disease, sponsored by Pfizer. Started Feb 2018; status: completed.
02
Drugs
ritlecitinib tosilatebrepocitinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03395184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395184.